179 related articles for article (PubMed ID: 29795338)
1. Distinctiveness in virological features and pathogenic potentials of subgenotypes D1, D2, D3 and D5 of Hepatitis B virus.
Khatun M; Mondal RK; Pal S; Baidya A; Bishnu D; Banerjee P; Santra AK; Dhali GK; Banerjee S; Chowdhury A; Datta S
Sci Rep; 2018 May; 8(1):8055. PubMed ID: 29795338
[TBL] [Abstract][Full Text] [Related]
2. Subgenotypes of hepatitis B virus genotype D (D1, D2, D3 and D5) in India: differential pattern of mutations, liver injury and occult HBV infection.
Chandra PK; Biswas A; Datta S; Banerjee A; Panigrahi R; Chakrabarti S; De BK; Chakravarty R
J Viral Hepat; 2009 Oct; 16(10):749-56. PubMed ID: 19457142
[TBL] [Abstract][Full Text] [Related]
3. Variability in the Responses of Hepatitis B Virus D-Subgenotypes to Antiviral Therapy: Designing Pan-D-Subgenotypic Reverse Transcriptase Inhibitors.
Khatun M; Kumar K; Baidya A; Mondal RK; Baszczyňski O; Kalčic F; Banerjee S; Dhali GK; Das K; Chowdhury A; Janeba Z; Chakrabarti S; Datta S
J Virol; 2022 Jan; 96(2):e0180021. PubMed ID: 34730399
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of hepatitis B virus reveals circulation of multiple subgenotypes of genotype D with clinically important mutations in central India.
Shivlata L; Pacholi S; Chouksey VK; Barde PV
Indian J Med Microbiol; 2021 Jan; 39(1):67-72. PubMed ID: 33515632
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic potential of hepatitis B virus subgenotype D1 surpasses D3: significance in the development of hepatocellular carcinoma.
Datta S; Dasgupta D; Ghosh A; Ghosh S; Manna A; Datta S; Chatterjee M; Chowdhury A; Banerjee S
Carcinogenesis; 2018 Feb; 39(2):283-292. PubMed ID: 29228221
[TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiology, phylogenetic analysis and genotype distribution of hepatitis B virus in Saudi Arabia: Predominance of genotype D1.
Al-Qahtani AA; Pourkarim MR; Trovão NS; Vergote V; Li G; Thijssen M; Abdo AA; Sanai FM; Dela Cruz D; Bohol MFF; Al-Anazi MR; Al-Ahdal MN
Infect Genet Evol; 2020 Jan; 77():104051. PubMed ID: 31634640
[TBL] [Abstract][Full Text] [Related]
7. D2: major subgenotype of hepatitis B virus in Russia and the Baltic region.
Tallo T; Tefanova V; Priimägi L; Schmidt J; Katargina O; Michailov M; Mukomolov S; Magnius L; Norder H
J Gen Virol; 2008 Aug; 89(Pt 8):1829-1839. PubMed ID: 18632953
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological history and genomic characterization of non-D1 HBV strains identified in Iran.
Pineda-Peña AC; Faria NR; Mina T; Amini-Bavil-Olyaee S; Alavian SM; Lemey P; Maes P; Van Ranst M; Pourkarim MR
J Clin Virol; 2015 Feb; 63():38-41. PubMed ID: 25600602
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B e Antigen Expression by Hepatitis B Virus Subgenotype A1 Relative to Subgenotypes A2 and D3 in Cultured Hepatocellular Carcinoma (Huh7) Cells.
Bhoola NH; Kramvis A
Intervirology; 2016; 59(1):48-59. PubMed ID: 27553619
[TBL] [Abstract][Full Text] [Related]
10. Reconstruction of the spatial and temporal dynamics of hepatitis B virus genotype D in the Americas.
Spitz N; Mello FCA; Moreira AS; Gusatti CS; Martins RMB; Gomes SA; Bello G; Araujo NM
PLoS One; 2019; 14(7):e0220342. PubMed ID: 31344111
[TBL] [Abstract][Full Text] [Related]
11. Unique hepatitis B virus subgenotype in a primitive tribal community in eastern India.
Ghosh S; Banerjee P; RoyChoudhury A; Sarkar S; Ghosh A; Santra A; Banerjee S; Das K; Dwibedi B; Kar SK; Rao VG; Bhat JT; Singh N; Chowdhury A; Datta S
J Clin Microbiol; 2010 Nov; 48(11):4063-71. PubMed ID: 20844228
[TBL] [Abstract][Full Text] [Related]
12. Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study.
Yin J; Zhang H; He Y; Xie J; Liu S; Chang W; Tan X; Gu C; Lu W; Wang H; Bi S; Cui F; Liang X; Schaefer S; Cao G
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):777-86. PubMed ID: 20160279
[TBL] [Abstract][Full Text] [Related]
13. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of HBV subgenotypes D.
Ozaras R; Inanc Balkan I; Yemisen M; Tabak F
Clin Res Hepatol Gastroenterol; 2015 Feb; 39(1):28-37. PubMed ID: 25037178
[TBL] [Abstract][Full Text] [Related]
15. Clonal analysis of hepatitis B viruses among blood donors from Joinville, Brazil: evidence of dual infections, intragenotype recombination and markers of risk for hepatocellular carcinoma.
Reis LM; Soares MA; França PH; Soares EA; Bonvicino CR
J Med Virol; 2011 Dec; 83(12):2103-12. PubMed ID: 22012717
[TBL] [Abstract][Full Text] [Related]
16. Genotyping and molecular characterization of hepatitis B virus in liver disease patients in Kenya.
Ochwoto M; Chauhan R; Gopalakrishnan D; Chen CY; Ng'ang'a Z; Okoth F; Kioko H; Kimotho J; Kaiguri P; Kramvis A
Infect Genet Evol; 2013 Dec; 20():103-10. PubMed ID: 23978387
[TBL] [Abstract][Full Text] [Related]
17. Characterization of hepatitis B virus in Turkish blood donors, and the prevalence of the SP1 splice variant.
Cox LE; Arslan O; Allain JP
J Med Virol; 2011 Aug; 83(8):1321-5. PubMed ID: 21678435
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus genotype and subgenotype prevalence and distribution in Montenegro.
Vratnica Z; Zehender G; Ebranati E; Sorrentino C; Lai A; Vujošević D; Veo C; Lo Presti A; Cella E; Giovanetti M; Laušević D; Galli M; Ciccozzi M; Mugoša B
J Med Virol; 2015 May; 87(5):807-13. PubMed ID: 25712706
[TBL] [Abstract][Full Text] [Related]
19. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.
Tseng TC; Liu CJ; Chen PJ; Lai MY; Lin CL; Kao JH; Chen DS
Liver Int; 2007 Sep; 27(7):983-8. PubMed ID: 17696938
[TBL] [Abstract][Full Text] [Related]
20. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
